BCL3, GBP1, IFI16, and CCR1 as potential brain-derived biomarkers for parietal grey matter lesions in multiple sclerosis

Bibliographic Details
Title: BCL3, GBP1, IFI16, and CCR1 as potential brain-derived biomarkers for parietal grey matter lesions in multiple sclerosis
Authors: Hua Guo, Zhaocheng Li, Yanqing Wang
Source: Scientific Reports, Vol 14, Iss 1, Pp 1-13 (2024)
Publisher Information: Nature Portfolio, 2024.
Publication Year: 2024
Collection: LCC:Medicine
LCC:Science
Subject Terms: Secondary progressive multiple sclerosis, Biomarkers, Bioinformatics, Machine learning, WGCNA, SPMS diagnosis, Medicine, Science
More Details: Abstract Multiple Sclerosis (MS) is a chronic autoimmune disease of the central nervous system, progressing from Relapsing–Remitting MS (RRMS) to Secondary Progressive MS (SPMS) in many cases. The transition involves complex biological changes. Our study aims to identify potential biomarkers for distinguishing SPMS by analyzing gene expression differences between normal-appearing and lesioned parietal grey matter, which may also contribute to understand the pathogenesis of SPMS. We utilized public datasets from the Gene Expression Omnibus (GEO), applying bioinformatics and machine learning techniques including Weighted Gene Co-expression Network Analysis (WGCNA), Kyoto Encyclopedia of Genes and Genomes (KEGG), Gene Ontology (GO) enrichment analysis, protein–protein interaction (PPI) networks, the Least Absolute Shrinkage and Selection Operator (LASSO), and Random Forest (RF) for predictive model construction. Our study also included analyses of immune cell infiltration. The study identified 359 DEGs, with 105 up-regulated and 254 down-regulated. WGCNA identified 264 common genes, which were subjected to KEGG and GO enrichment analyses, highlighting their role in immune response and viral infection pathways. Four genes (BCL3, GBP1, IFI16, and CCR1) were identified as key biomarkers for SPMS, supported by LASSO regression and RF analyses. These genes were further validated through receiver operating characteristic (ROC) curves, demonstrating significant predictive potential for SPMS. Our study provides a novel set of biomarkers for SPMS from lesioned grey matter of SPMS cases, offering potential for diagnosis and targeted therapeutic strategies. The identified biomarkers link closely with SPMS pathology, especially regarding immune system modulation.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2045-2322
64966496
Relation: https://doaj.org/toc/2045-2322
DOI: 10.1038/s41598-024-76949-y
Access URL: https://doaj.org/article/64966496a5a247b4bb3d93c7ae51c8f1
Accession Number: edsdoj.64966496a5a247b4bb3d93c7ae51c8f1
Database: Directory of Open Access Journals
Full text is not displayed to guests.
More Details
ISSN:20452322
64966496
DOI:10.1038/s41598-024-76949-y
Published in:Scientific Reports
Language:English